SCHEMBL3932976

SCHEMBL3932976

CN1CCCN(c2ccc(NC(=O)c3cc(NC(=O)c4ccnc(N5CCOCC5)c4)ccc3Cl)cn2)CC1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.60
PPARG P37231 3/20 0.58
RAB9A P51151 3/20 0.57
MAPT P10636 2/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 1/20 0.54
LMNA P02545 1/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
KCNQ3 O43525 1/20 0.51
KCNQ2 O43526 1/20 0.51
BRAF P15056 2/20 0.51
RAF1 P04049 1/20 0.51
LCK P06239 1/20 0.50
KDR P35968 1/20 0.50
MAPK13 O15264 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3938171 0.97 PPARG (0.61) MAPK14PPARGRAB9AMAPTCYP1A2
SCHEMBL3938272 0.88 PPARG (0.59) MAPK14PPARGRAB9AMAPTCYP1A2
SCHEMBL5897072 0.83 MAPK14 (0.64) MAPK14PPARGBRAFRAF1MAPK13
SCHEMBL6249153 0.81 PPARG (0.52) MAPK14PPARGRAB9ALMNAL3MBTL1
SCHEMBL6253060 0.81 MAPK13 (0.61) MAPK14PPARGRAB9AMAPTLMNA
SCHEMBL6254089 0.80 MAPK13 (0.61) MAPK14PPARGMAPTLMNASMN1; SMN2
SCHEMBL3933324 0.79 PPARG (0.52) MAPK14PPARGRAB9AMAPTCYP1A2
SCHEMBL3929810 0.78 MAPK14 (0.53) MAPK14PPARGRAB9AMAPTCYP1A2
SCHEMBL5896834 0.77 MAPK14 (0.66) MAPK14PPARGMAPTLMNAHTT
SCHEMBL27699896 0.77 SMN1; SMN2 (0.66) MAPK14PPARGRAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP claimed
EP-1831198-B1 PYRIDINE CARBOXAMIDE DERIVATIVES FOR USE AS ANTICANCER AGENTS ASTRAZENECA AB (SE) 2009-04-08 EP disclosed
WO-2006067445-A2 CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed